xCures Partners with the Pancreatic Cancer Action Network (PanCAN) xCures offers unparalleled access to data and the xINFORM patient portal to accelerate pancreatic cancer research and improve patient care
Oakland, CA
|
October 25, 2023 10:15 AM Eastern Daylight Time
xCures, a leader in real-time clinical data technology, is thrilled to announce a pivotal partnership with the Pancreatic Cancer Action Network (PanCAN).
As part of the agreement, PanCAN's researchers and grantees will have unparalleled access to xCures' deidentified Real-time, Regulatory-grade Clinical data.
This collaboration aims to drive innovations and breakthroughs in pancreatic cancer research by harnessing the power of real-time patient data. xCures database boasts fully longitudinal clinical data from thousands of pancreatic cancer patients, including over 25,000 locations and ~4,000 medical records per patient.
The benefits of this partnership extend beyond the research community. xCures is making its xINFORM patient portal available to PanCAN's leading Patient Services program.
The state-of-the-art portal aggregates and centralizes patients’ medical records and structures them into a computable format and an easy-to-understand longitudinal timeline.
The xINFORM portal supports patients in being matched with suitable treatments and clinical programs, obtaining invaluable second opinions.
Sudheer Doss, Ph.D., Chief Business Officer of PanCAN, shared his enthusiasm for the partnership: "We're always in search of innovative ways to serve our patient community better and accelerate pancreatic cancer research. As part of the comprehensive free services we offer through our PanCAN Patient Services program, this platform can pave the way for identifying optimal treatments and ensuring that our patients receive the best care possible."
The PanCAN-xCures partnership blends the strengths of both organizations to advance patient outcomes and bolster research capabilities.
“We at xCures are deeply committed to placing patients at the forefront of all our endeavors,” said Mika Newton, CEO of xCures. “This new partnership with PanCan is a testament to our dedication to advancing patient-centric solutions and strengthening our bond with patient advocacy organizations. Together, we will usher in a brighter, more hopeful future for all.”
About xCures
xCures Inc. operates an AI-assisted platform that automatically retrieves medical records from all sites of care.
The (unstructured) data is aggregated and organized into a powerful, up-to-date care summary that helps cancer patients get the right therapy at the right time.
The platform's portals, xINFORM for patients and xDECIDE for providers, facilitate treatment option decisions.
The research portal, xUTILITY, generates Real-time, Regulatory-grade, Clinical data (RRC) for studies and decentralized trials.
For more information, contact info@xcures.com or visit http://www.xcures.com.
About PanCAN
The Pancreatic Cancer Action Network (PanCAN) leads the way in accelerating critical progress for pancreatic cancer patients. PanCAN takes bold action by funding life-saving research, providing personalized patient services and creating a community of supporters and volunteers who will stop at nothing to create a world in which all pancreatic cancer patients will thrive. For 18 years in a row, PanCAN has earned a Four-Star Rating from Charity Navigator – the highest rating an organization can receive. This rating designates PanCAN as an official “Give with Confidence” charity, indicating strong financial health, ongoing accountability and transparency.
Contact Details
Patrick van der Valk
Company Website
